标题
The role of dissociation in ketamine’s antidepressant effects
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-12-22
DOI
10.1038/s41467-020-20190-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Psychedelics and Psychedelic-Assisted Psychotherapy
- (2020) Collin M. Reiff et al. AMERICAN JOURNAL OF PSYCHIATRY
- Psychedelic Psychiatry’s Brave New World
- (2020) David Nutt et al. CELL
- A New Paradigm for Achieving a Rapid Antidepressant Response
- (2020) Gin S. Malhi et al. DRUGS
- A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
- (2020) Lawrence T Park et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
- (2020) Cristan A. Farmer et al. NEUROPSYCHOPHARMACOLOGY
- Can ‘Floating’ Predict Treatment Response to Ketamine? Data from Three Randomized Trials of Individuals with Treatment-Resistant Depression
- (2020) Elia E. Acevedo-Diaz et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders
- (2020) Ege T. Kavalali et al. NEURON
- Deep posteromedial cortical rhythm in dissociation
- (2020) Sam Vesuna et al. NATURE
- Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
- (2020) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
- (2019) Samuel T. Wilkinson et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
- (2019) Elia E. Acevedo-Diaz et al. JOURNAL OF AFFECTIVE DISORDERS
- A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial
- (2019) Elias Dakwar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression
- (2019) Naji C. Salloum et al. JOURNAL OF AFFECTIVE DISORDERS
- The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
- (2019) David S. Mathai et al. JOURNAL OF AFFECTIVE DISORDERS
- Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder
- (2019) Rebecca McMillan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
- (2018) Jennifer W. Evans et al. BIOLOGICAL PSYCHIATRY
- Convergent Mechanisms Underlying Rapid Antidepressant Action
- (2018) Panos Zanos et al. CNS DRUGS
- Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale
- (2018) Gerrit I. van Schalkwyk et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
- (2018) Jessica L. Reed et al. NeuroImage-Clinical
- Vital Signs: Trends in State Suicide Rates — United States, 1999–2016 and Circumstances Contributing to Suicide — 27 States, 2015
- (2018) Deborah M. Stone et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
- (2018) Todd D. Gould et al. Annual Review of Pharmacology and Toxicology
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
- (2017) C A Zarate et al. MOLECULAR PSYCHIATRY
- Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
- (2017) Jerome H Taylor et al. NEUROPSYCHOPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
- (2016) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
- (2015) Lisa M Monteggia et al. CURRENT OPINION IN NEUROBIOLOGY
- Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
- (2015) SHELDON PRESKORN et al. Journal of Psychiatric Practice
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dissociative Disorders in DSM-5
- (2013) David Spiegel et al. Annual Review of Clinical Psychology
- Antidepressant Augmentation Using theN-Methyl-d-Aspartate Antagonist Memantine
- (2013) Eric G. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
- (2013) Carolyn I Rodriguez et al. NEUROPSYCHOPHARMACOLOGY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- GABAB-mediated rescue of altered excitatory–inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction
- (2012) M J Gandal et al. Translational Psychiatry
- Assuring That Double-Blind Is Blind
- (2010) Roy H. Perlis et al. AMERICAN JOURNAL OF PSYCHIATRY
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
- (2010) Erich Studerus et al. PLoS One
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now